G protein and MYD Growth Factor in neuroprotection after cerebral ischemia-reperfusion

Yisheng Cheng1, Xiaoxiao Cheng2, Han Zhao1

  • 1Department of Neurology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, Zhejiang, China.

Neurological Research
|June 15, 2025
PubMed
Abstract

Insights

Myeloid-Derived Growth Factor (MYDGF) protects the brain after stroke by activating key cell signaling pathways. Gαi1/3 is crucial for MYDGF

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Cerebral ischemia-reperfusion injury (CIRI) is a major cause of brain damage.
  • Understanding the molecular mechanisms underlying neuroprotection is critical for developing effective treatments.

Purpose of the Study:

  • To investigate the neuroprotective potential of Myeloid-Derived Growth Factor (MYDGF) in CIRI.
  • To elucidate the role of G protein-coupled signaling pathways in MYDGF-mediated neuroprotection.

Main Methods:

  • A mouse model of CIRI was established using middle cerebral artery occlusion (MCAO).
  • MYDGF and Gαi1/3 expression was modulated using shRNA and recombinant protein.
  • Gene and protein expression levels were analyzed using qRT-PCR and Western blot.
  • Cell-type specific knockdown in glial cells was performed using adenoviral shRNA.

Main Results:

  • MYDGF demonstrated significant neuroprotective effects in the CIRI model.
  • Activation of PI3K-AKT-mTOR and ERK-MAPK signaling pathways was observed.
  • Gαi1/3 was identified as a key mediator of MYDGF's neuroprotective actions.

Conclusions:

  • MYDGF confers neuroprotection against CIRI through the PI3K-AKT-mTOR and ERK-MAPK pathways.
  • Gαi1/3 plays a critical role in mediating the therapeutic effects of MYDGF.